It has been shown that TNF‐α can further promote the development of PAH by reducing the BMPR2 expression (a key factor in lung remodeling) in PASMCs, and baicalin can regulate the TNF‐α signaling pathway to prevent experimental PAH [35]. The gene discussed is TNF; the disease is pulmonary arterial hypertension.